Analysis of bleeding risk factors of low molecular weight heparin in prevention and treatment of tumor-associated venous thromboembolism

ZHANG Ziyu, ZHOU Houfeng, ZHANG Huiling, REN Changyu, LIAO Lankai

Chinese Journal of Hospital Pharmacy ›› 2024, Vol. 44 ›› Issue (11) : 1305-1309.

PDF(642 KB)
PDF(642 KB)
Chinese Journal of Hospital Pharmacy ›› 2024, Vol. 44 ›› Issue (11) : 1305-1309. DOI: 10.13286/j.1001-5213.2024.11.11
Drug and Clinical

Analysis of bleeding risk factors of low molecular weight heparin in prevention and treatment of tumor-associated venous thromboembolism

    {{javascript:window.custom_author_en_index=0;}}
  • {{article.zuoZhe_EN}}
Author information +
History +

HeighLight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

QR code of this article

Cite this article

Download Citations
{{article.zuoZheEn_L}}. {{article.title_en}}[J]. {{journal.qiKanMingCheng_EN}}, 2024, 44(11): 1305-1309 https://doi.org/10.13286/j.1001-5213.2024.11.11

References

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}
{{article.copyrightLicense_en}}
PDF(642 KB)

Accesses

Citation

Detail

Sections
Recommended

/